Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 209

1.

The ETS transcription factor ETV5 is a target of activated ALK in neuroblastoma contributing to increased tumour aggressiveness.

Mus LM, Lambertz I, Claeys S, Kumps C, Van Loocke W, Van Neste C, Umapathy G, Vaapil M, Bartenhagen C, Laureys G, De Wever O, Bexell D, Fischer M, Hallberg B, Schulte J, De Wilde B, Durinck K, Denecker G, De Preter K, Speleman F.

Sci Rep. 2020 Jan 14;10(1):218. doi: 10.1038/s41598-019-57076-5.

2.

Repotrectinib (TPX-0005), effectively reduces growth of ALK driven neuroblastoma cells.

Cervantes-Madrid D, Szydzik J, Lind DE, Borenäs M, Bemark M, Cui J, Palmer RH, Hallberg B.

Sci Rep. 2019 Dec 18;9(1):19353. doi: 10.1038/s41598-019-55060-7.

3.

Elevated levels of IL-6 and IGFBP-1 predict low serum IGF-1 levels during continuous infusion of rhIGF-1/rhIGFBP-3 in extremely preterm infants.

Klevebro S, Hellgren G, Hansen-Pupp I, Wackernagel D, Hallberg B, Borg J, Pivodic A, Smith L, Ley D, Hellström A.

Growth Horm IGF Res. 2019 Nov 9;50:1-8. doi: 10.1016/j.ghir.2019.11.001. [Epub ahead of print]

4.

Two-Year Neurodevelopmental Outcomes After Mild Hypoxic Ischemic Encephalopathy in the Era of Therapeutic Hypothermia.

Finder M, Boylan GB, Twomey D, Ahearne C, Murray DM, Hallberg B.

JAMA Pediatr. 2019 Nov 11. doi: 10.1001/jamapediatrics.2019.4011. [Epub ahead of print]

PMID:
31710357
5.

Analysis of ALK, MYCN, and the ALK ligand ALKAL2 (FAM150B/AUGα) in neuroblastoma patient samples with chromosome arm 2p rearrangements.

Javanmardi N, Fransson S, Djos A, Umapathy G, Östensson M, Milosevic J, Borenäs M, Hallberg B, Kogner P, Martinsson T, Palmer RH.

Genes Chromosomes Cancer. 2019 Jul 24. doi: 10.1002/gcc.22790. [Epub ahead of print]

PMID:
31340081
6.

Alectinib, an Anaplastic Lymphoma Kinase Inhibitor, Abolishes ALK Activity and Growth in ALK-Positive Neuroblastoma Cells.

Alam MW, Borenäs M, Lind DE, Cervantes-Madrid D, Umapathy G, Palmer RH, Hallberg B.

Front Oncol. 2019 Jul 5;9:579. doi: 10.3389/fonc.2019.00579. eCollection 2019.

7.

Adherence to oxygen saturation targets increased in preterm infants when a higher target range and tighter alarm limits were introduced.

Klevebro S, Hammar U, Holmström G, Bottai M, Hellström A, Hallberg B.

Acta Paediatr. 2019 Sep;108(9):1584-1589. doi: 10.1111/apa.14808. Epub 2019 Apr 25.

PMID:
30951230
8.

Leucocytosis is associated with retinopathy of prematurity in extremely preterm infants.

Lundgren P, Klevebro S, Brodin P, Smith LEH, Hallberg B, Hellström A.

Acta Paediatr. 2019 Jul;108(7):1357-1358. doi: 10.1111/apa.14798. Epub 2019 Apr 12. No abstract available.

9.

Association Between Year of Birth and 1-Year Survival Among Extremely Preterm Infants in Sweden During 2004-2007 and 2014-2016.

Norman M, Hallberg B, Abrahamsson T, Björklund LJ, Domellöf M, Farooqi A, Foyn Bruun C, Gadsbøll C, Hellström-Westas L, Ingemansson F, Källén K, Ley D, Maršál K, Normann E, Serenius F, Stephansson O, Stigson L, Um-Bergström P, Håkansson S.

JAMA. 2019 Mar 26;321(12):1188-1199. doi: 10.1001/jama.2019.2021.

10.

13PPhosphoproteome and gene expression profiling of ALK inhibition in neuroblastoma cell lines reveals conserved oncogenic pathways.

Umapathy G, Van den Eynden J, Cervantes-Madrid D, Szydzik J, Guan J, Palmer RH, Hallberg B.

Ann Oncol. 2019 Feb 1;30(Suppl 1). pii: mdz029.006. doi: 10.1093/annonc/mdz029.006. No abstract available.

PMID:
30810197
11.

Targeting anaplastic lymphoma kinase in neuroblastoma.

Umapathy G, Mendoza-Garcia P, Hallberg B, Palmer RH.

APMIS. 2019 May;127(5):288-302. doi: 10.1111/apm.12940. Epub 2019 Apr 3. Review.

12.

Individual variations in fentanyl pharmacokinetics and pharmacodynamics in preterm infants.

Norman E, Kindblom JM, Rane A, Berg AC, Schubert U, Hallberg B, Fellman V.

Acta Paediatr. 2019 Aug;108(8):1441-1446. doi: 10.1111/apa.14744. Epub 2019 Mar 19.

PMID:
30721546
13.

Prevalence of Severe Visual Disability Among Preterm Children With Retinopathy of Prematurity and Association With Adherence to Best Practice Guidelines.

Norman M, Hellström A, Hallberg B, Wallin A, Gustafson P, Tornqvist K, Håkansson S, Holmström G.

JAMA Netw Open. 2019 Jan 4;2(1):e186801. doi: 10.1001/jamanetworkopen.2018.6801.

14.

A Novel Scoring System for Term-Equivalent-Age Cranial Ultrasound in Extremely Preterm Infants.

Skiöld B, Hallberg B, Vollmer B, Ådén U, Blennow M, Horsch S.

Ultrasound Med Biol. 2019 Mar;45(3):786-794. doi: 10.1016/j.ultrasmedbio.2018.11.005. Epub 2019 Jan 2.

PMID:
30611572
15.

Validation of Altered Umbilical Cord Blood MicroRNA Expression in Neonatal Hypoxic-Ischemic Encephalopathy.

O'Sullivan MP, Looney AM, Moloney GM, Finder M, Hallberg B, Clarke G, Boylan GB, Murray DM.

JAMA Neurol. 2019 Mar 1;76(3):333-341. doi: 10.1001/jamaneurol.2018.4182.

16.

Development of a Retinopathy of Prematurity Activity Scale and Clinical Outcome Measures for Use in Clinical Trials.

Smith LEH, Hellström A, Stahl A, Fielder A, Chambers W, Moseley J, Toth C, Wallace D, Darlow BA, Aranda JV, Hallberg B, Davis JM; Retinopathy of Prematurity Workgroup of the International Neonatal Consortium.

JAMA Ophthalmol. 2019 Mar 1;137(3):305-311. doi: 10.1001/jamaophthalmol.2018.5984. Erratum in: JAMA Ophthalmol. 2019 Mar 1;137(3):328.

17.

RNA-sequencing analysis of umbilical cord plasma microRNAs from healthy newborns.

Brennan GP, Vitsios DM, Casey S, Looney AM, Hallberg B, Henshall DC, Boylan GB, Murray DM, Mooney C.

PLoS One. 2018 Dec 3;13(12):e0207952. doi: 10.1371/journal.pone.0207952. eCollection 2018.

18.

rhIGF-1/rhIGFBP-3 in Preterm Infants: A Phase 2 Randomized Controlled Trial.

Ley D, Hallberg B, Hansen-Pupp I, Dani C, Ramenghi LA, Marlow N, Beardsall K, Bhatti F, Dunger D, Higginson JD, Mahaveer A, Mezu-Ndubuisi OJ, Reynolds P, Giannantonio C, van Weissenbruch M, Barton N, Tocoian A, Hamdani M, Jochim E, Mangili A, Chung JK, Turner MA, Smith LEH, Hellström A; study team.

J Pediatr. 2019 Mar;206:56-65.e8. doi: 10.1016/j.jpeds.2018.10.033. Epub 2018 Nov 22.

19.

Phosphoproteome and gene expression profiling of ALK inhibition in neuroblastoma cell lines reveals conserved oncogenic pathways.

Van den Eynden J, Umapathy G, Ashouri A, Cervantes-Madrid D, Szydzik J, Ruuth K, Koster J, Larsson E, Guan J, Palmer RH, Hallberg B.

Sci Signal. 2018 Nov 20;11(557). pii: eaar5680. doi: 10.1126/scisignal.aar5680.

PMID:
30459281
20.

Thrombocytopenia is associated with severe retinopathy of prematurity.

Cakir B, Liegl R, Hellgren G, Lundgren P, Sun Y, Klevebro S, Löfqvist C, Mannheimer C, Cho S, Poblete A, Duran R, Hallberg B, Canas J, Lorenz V, Liu ZJ, Sola-Visner MC, Smith LE, Hellström A.

JCI Insight. 2018 Oct 4;3(19). pii: 99448. doi: 10.1172/jci.insight.99448.

21.

Validation of Raised Cord Blood Interleukin-16 in Perinatal Asphyxia and Neonatal Hypoxic-Ischaemic Encephalopathy in the BiHiVE2 Cohort.

O'Sullivan MP, Sikora KM, Ahearne C, Twomey DM, Finder M, Boylan GB, Hallberg B, Murray DM.

Dev Neurosci. 2018;40(3):271-277. doi: 10.1159/000491386. Epub 2018 Sep 11.

PMID:
30205414
22.

Altered Expression of Umbilical Cord Blood Levels of miR-181b and Its Downstream Target mUCH-L1 in Infants with Moderate and Severe Neonatal Hypoxic-Ischaemic Encephalopathy.

Looney AM, O'Sullivan MP, Ahearne CE, Finder M, Felderhoff-Mueser U, Boylan GB, Hallberg B, Murray DM.

Mol Neurobiol. 2019 May;56(5):3657-3663. doi: 10.1007/s12035-018-1321-4. Epub 2018 Sep 3.

PMID:
30178296
23.

Kylbehandling av nyfödda har minskat svåra skador.

Norman M, Hallberg B.

Lakartidningen. 2018 Aug 22;115. pii: E9TH. Swedish. No abstract available.

24.

Traumatic shaking: The role of the triad in medical investigations of suspected traumatic shaking.

Elinder G, Eriksson A, Hallberg B, Lynøe N, Sundgren PM, Rosén M, Engström I, Erlandsson BE.

Acta Paediatr. 2018 Sep;107 Suppl 472:3-23. doi: 10.1111/apa.14473.

25.

Clinical response of the novel activating ALK-I1171T mutation in neuroblastoma to the ALK inhibitor ceritinib.

Guan J, Fransson S, Siaw JT, Treis D, Van den Eynden J, Chand D, Umapathy G, Ruuth K, Svenberg P, Wessman S, Shamikh A, Jacobsson H, Gordon L, Stenman J, Svensson PJ, Hansson M, Larsson E, Martinsson T, Palmer RH, Kogner P, Hallberg B.

Cold Spring Harb Mol Case Stud. 2018 Aug 1;4(4). pii: a002550. doi: 10.1101/mcs.a002550. Print 2018 Aug.

26.

Swedish consensus reached on recording, interpretation and reporting of neonatal continuous simplified electroencephalography that is supported by amplitude-integrated trend analysis.

Backman S, Rosén I, Blennow M, Andersson T, Englund M, Flink R, Hallberg B, Liedholm LJ, Norman E, Sailer A, Thordstein M.

Acta Paediatr. 2018 Oct;107(10):1702-1709. doi: 10.1111/apa.14460. Epub 2018 Jul 12.

PMID:
29897141
27.

Early energy and protein intakes and associations with growth, BPD, and ROP in extremely preterm infants.

Klevebro S, Westin V, Stoltz Sjöström E, Norman M, Domellöf M, Edstedt Bonamy AK, Hallberg B.

Clin Nutr. 2019 Jun;38(3):1289-1295. doi: 10.1016/j.clnu.2018.05.012. Epub 2018 May 29.

28.

Hyperglycemia in Extremely Preterm Infants-Insulin Treatment, Mortality and Nutrient Intakes.

Zamir I, Tornevi A, Abrahamsson T, Ahlsson F, Engström E, Hallberg B, Hansen-Pupp I, Sjöström ES, Domellöf M.

J Pediatr. 2018 Sep;200:104-110.e1. doi: 10.1016/j.jpeds.2018.03.049. Epub 2018 May 3.

PMID:
29731360
29.

Easier to see the speck in your critical peers' eyes than the log in your own? Response to Debelle et al.

Lynøe N, Elinder G, Hallberg B, Rosén M, Sundgren P, Eriksson A.

Arch Dis Child. 2018 Jul;103(7):714. doi: 10.1136/archdischild-2018-315380. Epub 2018 May 4. No abstract available.

PMID:
29728419
30.

Improved nutrition for extremely preterm infants - A population based observational study.

Westin V, Klevebro S, Domellöf M, Vanpée M, Hallberg B, Stoltz Sjöström E.

Clin Nutr ESPEN. 2018 Feb;23:245-251. doi: 10.1016/j.clnesp.2017.09.004. Epub 2017 Oct 10.

PMID:
29460807
31.

Wait a minute? An observational cohort study comparing iron stores in healthy Swedish infants at 4 months of age after 10-, 60- and 180-second umbilical cord clamping.

Askelöf U, Andersson O, Domellöf M, Fasth A, Hallberg B, Hellström-Westas L, Pettersson K, Westgren M, Wiklund IE, Götherström C.

BMJ Open. 2017 Dec 29;7(12):e017215. doi: 10.1136/bmjopen-2017-017215.

32.

A Novel Magnetic Resonance Imaging Score Predicts Neurodevelopmental Outcome After Perinatal Asphyxia and Therapeutic Hypothermia.

Weeke LC, Groenendaal F, Mudigonda K, Blennow M, Lequin MH, Meiners LC, van Haastert IC, Benders MJ, Hallberg B, de Vries LS.

J Pediatr. 2018 Jan;192:33-40.e2. doi: 10.1016/j.jpeds.2017.09.043.

33.

MEK inhibitor trametinib does not prevent the growth of anaplastic lymphoma kinase (ALK)-addicted neuroblastomas.

Umapathy G, Guan J, Gustafsson DE, Javanmardi N, Cervantes-Madrid D, Djos A, Martinsson T, Palmer RH, Hallberg B.

Sci Signal. 2017 Nov 28;10(507). pii: eaam7550. doi: 10.1126/scisignal.aam7550.

PMID:
29184034
34.

Novel Mechanisms of ALK Activation Revealed by Analysis of the Y1278S Neuroblastoma Mutation.

Guan J, Yamazaki Y, Chand D, van Dijk JR, Ruuth K, Palmer RH, Hallberg B.

Cancers (Basel). 2017 Oct 30;9(11). pii: E149. doi: 10.3390/cancers9110149.

35.

Pouring out the dirty bathwater without throwing away either the baby or its parents: commentary to Saunders et al.

Lynøe N, Rosén M, Elinder G, Hallberg B, Sundgren P, Eriksson A.

Pediatr Radiol. 2018 Feb;48(2):284-286. doi: 10.1007/s00247-017-4003-x. Epub 2017 Oct 23. No abstract available.

36.

The MRPP1/MRPP2 complex is a tRNA-maturation platform in human mitochondria.

Reinhard L, Sridhara S, Hällberg BM.

Nucleic Acids Res. 2017 Dec 1;45(21):12469-12480. doi: 10.1093/nar/gkx902.

37.

IGF-1 as a Drug for Preterm Infants: A Step-Wise Clinical Development.

Hellstrom A, Ley D, Hallberg B, Lofqvist C, Hansen-Pupp I, Ramenghi LA, Borg J, Smith LEH, Hard AL.

Curr Pharm Des. 2017;23(38):5964-5970. doi: 10.2174/1381612823666171002114545. Review.

38.

Continuous longitudinal infusion of rhIGF-1/rhIGFBP-3 in extremely preterm infants: Evaluation of feasibility in a phase II study.

Hansen-Pupp I, Hellström A, Hamdani M, Tocoian A, Kreher NC, Ley D, Hallberg B.

Growth Horm IGF Res. 2017 Oct;36:44-51. doi: 10.1016/j.ghir.2017.08.004. Epub 2017 Aug 31.

39.

Shaken baby syndrome and the risk of losing scientific scrutiny.

Rosén M, Lynøe N, Elinder G, Hallberg B, Sundgren P, Eriksson A.

Acta Paediatr. 2017 Dec;106(12):1905-1908. doi: 10.1111/apa.14056. Epub 2017 Oct 10. Review.

PMID:
28871599
40.

Is accepting circular reasoning in shaken baby studies bad science or misconduct?

Lynøe N, Elinder G, Hallberg B, Rosén M, Sundgren P, Eriksson A.

Acta Paediatr. 2017 Sep;106(9):1445-1446. doi: 10.1111/apa.13947. Epub 2017 Jul 10. No abstract available.

PMID:
28608979
41.

The scientific evidence regarding retinal haemorrhages. Response to Hellgren et al. and Levin.

Lynøe N, Elinder G, Hallberg B, Rosén M, Sundgren P, Eriksson A.

Acta Paediatr. 2017 Jul;106(7):1041-1042. doi: 10.1111/apa.13896. Epub 2017 May 19. No abstract available.

PMID:
28543742
42.

A misunderstanding. Response to Dr Bilo et al.

Lynøe N, Elinder G, Hallberg B, Rosén M, Sundgren P, Eriksson A.

Acta Paediatr. 2017 Jul;106(7):1046. doi: 10.1111/apa.13892. Epub 2017 May 22. No abstract available.

PMID:
28440883
43.

What are acceptable conclusions? Response to Dr. Ludvigsson.

Lynøe N, Elinder G, Hallberg B, Rosén M, Sundgren P, Eriksson A.

Acta Paediatr. 2017 Jul;106(7):1032. doi: 10.1111/apa.13890. Epub 2017 May 29. No abstract available.

PMID:
28437603
44.

The shaken baby syndrome report was not the result of a conspiracy. Response to Dr. Narang et al.

Lynøe N, Elinder G, Hallberg B, Rosén M, Sundgren P, Eriksson A.

Acta Paediatr. 2017 Jul;106(7):1050-1051. doi: 10.1111/apa.13895. No abstract available.

PMID:
28437569
45.

Conflicts of interest issues. Response to Lucas et al.

Lynøe N, Elinder G, Hallberg B, Rosén M, Sundgren P, Eriksson A.

Acta Paediatr. 2017 Jul;106(7):1036. doi: 10.1111/apa.13891. Epub 2017 May 22. No abstract available.

PMID:
28437564
46.

Authors' overarching reply to all the responses received to the systematic literature review on shaken baby syndrome.

Lynøe N, Elinder G, Hallberg B, Rosén M, Sundgren P, Eriksson A.

Acta Paediatr. 2017 Jul;106(7):1031. doi: 10.1111/apa.13887. Epub 2017 May 19. No abstract available.

PMID:
28437023
47.

SnoN Stabilizes the SMAD3/SMAD4 Protein Complex.

Walldén K, Nyman T, Hällberg BM.

Sci Rep. 2017 Apr 11;7:46370. doi: 10.1038/srep46370.

48.

Parents' presence and parent-infant closeness in 11 neonatal intensive care units in six European countries vary between and within the countries.

Raiskila S, Axelin A, Toome L, Caballero S, Tandberg BS, Montirosso R, Normann E, Hallberg B, Westrup B, Ewald U, Lehtonen L.

Acta Paediatr. 2017 Jun;106(6):878-888. doi: 10.1111/apa.13798. Epub 2017 Mar 31.

49.

Insufficient evidence for 'shaken baby syndrome' - a systematic review.

Lynøe N, Elinder G, Hallberg B, Rosén M, Sundgren P, Eriksson A.

Acta Paediatr. 2017 Jul;106(7):1021-1027. doi: 10.1111/apa.13760. Epub 2017 Mar 1. Review.

PMID:
28130787
50.

Corrigendum to "Parent and nurse perceptions on the quality of family-centered care in 11 European NICUs" [Aust. Crit. Care 29 (4) (2016) 201-209].

Raiskila S, Lehtonen L, Silnes Tandberg B, Normann E, Ewald U, Caballero S, Varendi H, Toome L, Nordhøv M, Hallberg B, Westrup B, Montirosso R, Axelin A.

Aust Crit Care. 2017 Jan;30(1):53-54. doi: 10.1016/j.aucc.2016.12.002. No abstract available.

PMID:
28041568

Supplemental Content

Loading ...
Support Center